지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
Yonsei Medical Journal
2020 .01
Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Journal of Gynecologic Oncology
2019 .01
Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
Investigative and Clinical Urology
2020 .01
Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
Yonsei Medical Journal
2020 .01
Impact of Neoadjuvant Chemotherapy on the Local Recurrence in Breast Cancer Patients with Clinical T2
대한외과학회 학술대회 초록집
2021 .05
Impact of Molecular Subtype Conversion of Breast Cancers after Neoadjuvant Chemotherapy on Clinical Outcome
Cancer Research and Treatment
2016 .01
Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
Journal of Gastric Cancer
2023 .01
Role of Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first- line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
Journal of Gynecologic Oncology
2022 .11
Clinical Outcomes of Neoadjuvant Chemotherapy in Colorectal Cancer Patients With Synchronous Resectable Liver Metastasis: A Propensity Score Matching Analysis
Annals of Coloproctology
2021 .08
난소암의 수술적 치료
대한의사협회지
2016 .01
Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
Cancer Research and Treatment
2020 .01
Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients
Investigative and Clinical Urology
2024 .05
Effect of Interval Between Neoadjuvant Chemotherapy and Surgery on Oncological Outcomes in Poor Responders With Locally Advanced Breast Cancer
Journal of Breast Cancer
2024 .08
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis
Journal of Gynecologic Oncology
2022 .07
Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea
Journal of Korean Medical Science
2015 .01
Safety and feasibility of robotic surgery in selected ovarian cancer patients undergoing interval debulking surgery
Obstetrics & Gynecology Science
2020 .01
Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
Journal of Gynecologic Oncology
2023 .03
Complete response after neoadjuvant chemotherapy for breast cancer: biopsy alone vs radical surgery
대한임상종양학회 학술대회지
2021 .06
[Breast] Risk Factors of Breast Cancer Recurrence in Pathologic Complete Response (pCR) Achieved Post Neoadjuvant Chemotherapy (NAC) Patients
대한외과학회 학술대회 초록집
2022 .11
0